1 Kochhar A,Hildebrand MS,Smith RJ.Clinical aspects of hereditary hearing loss[J].Genet Med,2007,9:393.

2 Milunsky JM,Maher TA,Ito M,et al.The value of MLPA in Waardenburg syndrome[J].Genet Test,2007,11:179.

3 Pingault V,Ente D,Dastot-Le Moal F,et al.Review and update of mutations causing Waardenburg syndrome[J].Hum Mutat,2010,31:391.

4 Kubic JD,Young KP,Plummer RS,et al.Pigmentation PAX-ways:the role of Pax3in melanogenesis,melanocyte stem cell maintenance,and disease[J].Pigment Cell Melanoma Res,2008,21:627.

5 Wu M,Li J,Engleka KA,et al.Persistent expression of Pax3in the neural crest causes cleft palate and defective osteogenesis in mice[J].J Clin Invest,2008,118:2 076.

6 Potterf SB,Furumura M,Dunn KJ,et al.Transcription factor hierarchy in Waardenburg syndrome:regulation of MITF expression by SOX10and PAX3[J].Hum Genet,2000,107:1.

7 Lang D,Epstein JA.Sox10and Pax3physically interact to mediate activation of a conserved c-RET enhancer[J].Hum Mol Genet,2003,12:937.

8 Zhang H,Chen H,Luo H,et al.Functional analysis of Waardenburg syndrome-associated PAX3and SOX10 mutations:report of a dominant-negative SOX10mutation in Waardenburg syndrome type II[J].Hum Genet,2012,131:491.

9 Cao Y,Wang C.The COOH-terminal transactivation domain plays a key role in regulating the in vitro and in vivo function of Pax3homeodomain[J].J Biol Chem,2000,275:9 854.

10 Corry GN,Raghuram N,Missiaen KK,et al.The PAX3paired domain and homeodomain function as a single binding module in vivo to regulate subnuclear localization and mobility by a mechanism that requires base-specific recognition[J].J Mol Biol,2010,402:178.

11 Hoth CF,Milunsky A,Lipsky N,et al.Mutations in the paired domain of the human PAX3gene cause Klein-Waardenburg syndrome(WS-III)as well as Waardenburg syndrome type I(WS-I)[J].Am J Hum Genet,1993,52:455.

12 Epstein DJ,Vogan KJ,Trasler DG,et al.A mutation within intron 3of the Pax-3gene produces aberrantly spliced mRNA transcripts in the splotch(Sp)mouse mutant[J].Proc Natl Acad Sci USA,1993,90:532.

13 Wollnik B,Tukel T,Uyguner O,et al.Homozygous and heterozygous inheritance of PAX3mutations causes different types of Waardenburg syndrome[J].Am J Med Genet A,2003,122A:42.

14 Le Douarin NM,Creuzet S,Couly G,et al.Neural crest cell plasticity and its limits[J].Development,2004,131:4 637.

15 Trainor PA.Specification and patterning of neural crest cells during craniofacial development[J].Brain Behav Evol,2005,66:266.

16 Crane JF,Trainor PA.Neural crest stem and progenitor cells[J].Annu Rev Cell Dev Biol,2006,22:267.

17 Dupin E,Le Douarin NM.Development of melanocyte precursors from the vertebrate neural crest[J].Oncogene,2003,22:3 016.

18 Sauka-Spengler T,Bronner-Fraser M.Development and evolution of the migratory neural crest:agene regulatory perspective[J].Curr Opin Genet Dev,2006,16:360.

19 Brito FC,Kos L.Timeline and distribution of melanocyte precursors in the mouse heart[J].Pigment Cell Melanoma Res,2008,21:464.

20 Steingrimsson E,Copeland NG,Jenkins NA.Melanocytes and the microphthalmia transcription factor network[J].Annu Rev Genet,2004,38:365.

21 Yajima I,Larue L.The location of heart melanocytes is specified and the level of pigmentation in the heart may correlate with coat color[J].Pigment Cell Melanoma Res,2008,21:471.

22 Tachibana M,Kobayashi Y,Matsushima Y.Mouse models for four types of Waardenburg syndrome[J].Pigment Cell Res,2003,16:448.

23 Fenby BT,Fotaki V,Mason JO.Pax3regulates Wnt1expression via a conserved binding site in the 5'proximal promoter[J].Biochim Biophys Acta,2008,1779:115.

24 Mayanil CS,Pool A,Nakazaki H,et al.Regulation of murine TGFbeta2by Pax3during early embryonic development[J].J Biol Chem,2006,281:24 544.

25 de Groot JW,Links TP,Plukker JT,et al.RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors[J].Endocr Rev,2006,27:535.

26 Wu J,Saint-Jeannet JP,Klein PS.Wnt-frizzled signaling in neural crest formation[J].Trends Neurosci,2003,26:40.

27 Soma T,Tsuji Y,Hibino T.Involvement of transforming growth factor-beta2in catagen induction during the human hair cycle[J].J Invest Dermatol,2002,118:993.

28 Lang D,Lu MM,Huang L,et al.Pax3functions at a nodal point in melanocyte stem cell differentiation[J].Nature,2005,433:884.

29 Corry GN,Underhill DA.Pax3target gene recognition occurs through distinct modes that are differentially affected by disease-associated mutations[J].Pigment Cell Res,2005,18:427.

30 Bondurand N,Pingault V,Goerich DE,et al.Interaction among SOX10,PAX3 and MITF,three genes altered in Waardenburg syndrome[J].Hum Mol Genet,2000,9:1 907.

31 Smit DJ,Smith AG,Parsons PG,et al.Domains of Brn-2that mediate homodimerization and interaction with general and melanocytic transcription factors[J].Eur J Biochem,2000,267:6 413.

32 Matsunaga T,Mutai H,Namba K,et al.Genetic analysis of PAX3for diagnosis of Waardenburg syndrome[J].Acta Otolaryngol,2013,133:345.

33 Birrane G,Soni A,Ladias JA.Structural basis for DNA recognition by the human PAX3homeodomain[J].Biochemistry,2009,48:1 148.

34 Chi YI.Homeodomain revisited:a lesson from disease-causing mutations[J].Hum Genet,2005,116:433.

35 Corry GN,Hendzel MJ,Underhill DA.Subnuclear localization and mobility are key indicators of PAX3dysfunction in Waardenburg syndrome[J].Hum Mol Genet,2008,17:1 825.